More Sleepless Nights For Pharma Over EU Labeling Rule For Investigational Drugs
This article was originally published in SRA
Executive Summary
A controversial drug labeling rule in the EU's Clinical Trials Regulation might already be having undesirable consequences, even though the legislation will not kick in for a couple of years.